MERCURY PHARMA GROUP LIMITED

02330913
Active London

Manufacture of basic pharmaceutical products

0 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products
M

MERCURY PHARMA GROUP LIMITED

02330913

Manufacture of basic pharmaceutical products

Founded 23 Dec 1988 Active London, United Kingdom 0 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products

Previous Company Names

GOLDSHIELD GROUP LIMITED 15 Jan 2010 — 20 Mar 2012
GOLDSHIELD GROUP PLC 8 May 1998 — 4 Jan 2010
GOLDSHIELD PHARMACEUTICALS (EUROPE) LIMITED 2 Jul 1992 — 8 May 1998
GOLDCREST PHARMACEUTICALS (EUROPE) LIMITED 26 Sept 1989 — 2 Jul 1992
SETBIT LIMITED 23 Dec 1988 — 26 Sept 1989
Accounts Submitted 7 Oct 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 21 Jul 2025 Next due 21 Jul 2026 1 month remaining
Net assets £1,154M £22M 2024 year on year
Total assets £1,370M £135M 2024 year on year
Total Liabilities £216M £113M 2024 year on year
Charges 28
7 outstanding 21 satisfied

Contact & Details

Contact

Registered Address

Dashwood House 69 Old Broad Street London EC2M 1QS United Kingdom

Telephone

0800 000 0000

Website

www.example.com

Full company profile for MERCURY PHARMA GROUP LIMITED (02330913), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 23 Dec 1988. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2014–2024)

Cash in Bank

£1.73M

Decreased by £9.64M (-85%)

Net Assets

£1154.00M

Decreased by £21.70M (-2%)

Total Liabilities

£215.80M

Decreased by £113.06M (-34%)

Turnover

£282.88M

Decreased by £31.41M (-10%)

Employees

N/A

Debt Ratio

16%

Decreased by 6 (-27%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 2,827,094,510 Shares £1036130137915.00m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
1 Jul 20222,827,094,510$1036130137915.00m$366.50m

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Advanz Pharma Corp. Limited
100.0%

Persons with Significant Control

Persons with Significant Control (0)

0 Active 3 Ceased

The Blackstone Group Inc.

Ceased 1 Jun 2021

Ceased

Group Structure

Group Structure

MERCURY PHARMA GROUP LIMITED Current Company

Charges

Charges

7 outstanding 21 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
5 May 2026OfficersAppointment of Mr Amaar Fainan Idris as director on 7 Apr 2026
17 Feb 2026CapitalAllotment of shares (USD 366,500,000) on 28 Sept 2022
7 Oct 2025AccountsAnnual accounts made up to 31 Dec 2024
21 Jul 2025Confirmation StatementConfirmation statement made on 7 Jul 2025 with no updates
22 May 2025MortgageMortgage Create With Deed With Charge Number Charge Creation Date
5 May 2026 Officers

Appointment of Mr Amaar Fainan Idris as director on 7 Apr 2026

17 Feb 2026 Capital

Allotment of shares (USD 366,500,000) on 28 Sept 2022

7 Oct 2025 Accounts

Annual accounts made up to 31 Dec 2024

21 Jul 2025 Confirmation Statement

Confirmation statement made on 7 Jul 2025 with no updates

22 May 2025 Mortgage

Mortgage Create With Deed With Charge Number Charge Creation Date

Recent Activity

Latest Activity

Appointment of Mr Amaar Fainan Idris as director on 7 Apr 2026

1 months ago on 5 May 2026

Allotment of shares (USD 366,500,000) on 28 Sept 2022

3 months ago on 17 Feb 2026

Annual accounts made up to 31 Dec 2024

8 months ago on 7 Oct 2025

Confirmation statement made on 7 Jul 2025 with no updates

11 months ago on 21 Jul 2025

Mortgage Create With Deed With Charge Number Charge Creation Date

1 years ago on 22 May 2025